Twist Bioscience Cash Flow Statement
NASDAQ: TWSTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Twist Bioscience free cash flow
In fiscal 2025, Twist Bioscience generated -$47.6 million of operating cash flow and spent $28.0 million on capital expenditures. That left free cash flow of -$75.6 million, a free-cash-flow margin of -20.1% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Twist Bioscience cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-09-30 | FY 20242024-09-30 | FY 20232023-09-30 | FY 20222022-09-30 | FY 20212021-09-30 | FY 20202020-09-30 | FY 20192019-09-30 | FY 20182018-09-30 | FY 20172017-09-30 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -77.67M | -208.73M | -204.62M | -217.86M | -152.10M | -139.93M | -107.67M | -71.24M | -59.31M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 24.85M | 31.43M | 29.31M | 16.51M | 9.75M | 6.68M | 6.11M | 5.73M | 5.02M |
| Stock-Based Compensation | 64.46M | 50.92M | 30.28M | 79.66M | 37.00M | 17.10M | 11.17M | 2.96M | 1.89M |
| Change in Working Capital | -14.38M | 2.69M | -3.86M | -19.75M | -15.23M | -26.44M | -4.21M | -5.23M | -1.34M |
| Operating Cash Flow | -47.63M | -64.09M | -142.47M | -124.39M | -112.24M | -142.25M | -87.94M | -66.16M | -51.30M |
| Capital Expenditures | -28.00M | -5.08M | -27.78M | -101.86M | -27.06M | -9.87M | -14.76M | -3.69M | -6.59M |
| Investing Cash Flow | -24.76M | -3.07M | 50.61M | -232.93M | 156.16M | -114.65M | -104.81M | 27.31M | -9.99M |
| Debt Issued | — | — | — | — | — | — | — | — | 2.17M |
| Debt Repaid | — | 0 | 0 | -1.56M | -3.33M | -3.33M | -2.50M | — | -4.17M |
| Financing Cash Flow | 28.54M | 6.89M | 911.00K | 270.53M | 329.18M | 303.73M | 158.58M | 88.82M | 63.80M |
| Net Change in Cash | -43.71M | -60.15M | -90.98M | -87.10M | 373.11M | 46.85M | -34.14M | 49.96M | 2.51M |
| Free Cash Flow | -75.63M | -69.17M | -170.25M | -226.24M | -139.31M | -152.12M | -102.69M | -69.85M | -57.90M |
This table shows 9 annual periods of Twist Bioscience's cash flow statement, from FY 2025 back to FY 2017, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow TWST's reporting calendar. What is a cash flow statement?